Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome.

Thrombosis research - 1 Jun 2011

Ames Paul R J, Margaglione Maurizio, Ciampa Antonio, Colaizzo Donatella, Ferrara Felicetto, Iannaccone Luigi, Vincenzobrancaccio

Abstract excerpt

INTRODUCTION: Anedoctal reports suggest that some thrombotic primary antiphospholipid antibody syndrome (PAPS) patients on oral anticoagulation require higher than average doses to achieve given targets international normalized ratios (INR). MATERIALS AND METHODS: To test the hypothesis of relative warfarin resistance in thrombotic PAPS and the effect of baseline IgG anticardiolipin antibodies, the cytochrome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antiphospholipid
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiphospholipid Syndrome

Share to Cytochrome P-450 CYP2C9

Share to Fibrin

Share to International Normalized Ratio

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 21371740
DOI: 10.1016/j.thromres.2011.01.014

Genes

VKORC1
GPI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome.PMID 21371740Read ↗

Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.Semantic proximity Read ↗

Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?Semantic proximity Read ↗

[Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].Semantic proximity Read ↗

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.Semantic proximity Read ↗

Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.Semantic proximity Read ↗

The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome.Semantic proximity Read ↗

Platelet glycoprotein Ibalpha polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease.Semantic proximity Read ↗

Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.